Apolipoprotein B Gene Polymorphisms and Dyslipidemia in HIV Infected Adult Zimbabweans
The Open AIDS Journal · 30.09.2016 · 10 (1) · 190-198
DOI: 10.2174/1874613601610010190 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Open AIDS Journal, erschienen am 30.09.2016. Verfasst von Vitaris Kodogo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Sciences, College of Health Sciences, University of Zimbabwe, Harare, Zimbabwe. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Dyslipidemia does not occur in all HIV-infected or antiretroviral therapy-experienced patients suggesting role of host genetic factors but there is paucity of data on association between dyslipidemia and gene polymorphisms in Zimbabwe.
Objective
To determine association of lipoprotein levels and apolipoprotein B polymorphisms in HIV-infected adults.
Method
Demographic data were collected from 103 consenting patients; lipoprotein levels were determined and blood samples were successfully genotyped for both apolipoprotein B 2488C>T Xba1 and apolipoprotein B 4154G>A p.Gln4154Lys EcoR1 polymorphisms by real time polymerase chain reaction.
Results
Mean age of genotyped patients was 40.3 ± 10.1 years, 68% were female; prevalence of dyslipidemia was 67.4%. Of 103 samples genotyped for apolipoprotein B Xba1 polymorphism, 76 (74%) were homozygous C/C, 24 (23%) were heterozygous C/T and only three (3%) were homozygous T/T. Apolipoprotein B EcoR1 polymorphism showed little variability, one participant had rare genotype A/A, 68.3% had wild type genotype G/G.
Conclusion
Observed frequencies of apolipoprotein B XbaI and EcoRI polymorphisms matched other African studies. In spite of low numbers of rare variants, there was positive association between both total cholestrol and high density lipoprotein with ECoR1 wild type G/G genotype, suggesting that ECoRI 4154 G allele could be more protective against coronary heart disease than EcoR1 4154 A allele. There is need for further research at population level to confirm whether apolipoprotein B ECoR1 genotyping is useful for predicting risk of dyslipidemia in HIV patients in our setting.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Laboratory Sciences, College of Health Sciences, University of Zimbabwe, Harare, Zimbabwe.
- Department of Medical Laboratory Sciences, College of Health Sciences, University of Zimbabwe, Harare, Zimbabwe; Institute of Clinical Medicine, Oslo University Hospital, Oslo, Norway.
- Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway.
- Department of Immunology, College of Health Sciences, University of Zimbabwe, Harare, Zimbabwe.
- Institute of Clinical Medicine, University in Oslo, and Womens Clinic, Oslo University Hospital, Oslo, Norway.
Zitieren
APA
Kodogo, V., Zhou, D. T., Oektedalen, O., Duri, K., Stray-Pedersen, B., & Gomo, E. (2016). Apolipoprotein B Gene Polymorphisms and Dyslipidemia in HIV Infected Adult Zimbabweans. The Open AIDS Journal, 10(1), 190-198. https://doi.org/10.2174/1874613601610010190
Vancouver
Kodogo V, Zhou DT, Oektedalen O, Duri K, Stray-Pedersen B, Gomo E. Apolipoprotein B Gene Polymorphisms and Dyslipidemia in HIV Infected Adult Zimbabweans. The Open AIDS Journal. 2016;10(1):190-198. doi:10.2174/1874613601610010190
BibTeX
@article{Kodogo2016,
author = {Kodogo, Vitaris and Zhou, Danai Tavonga and Oektedalen, Olav and Duri, Kerina and Stray-Pedersen, Babill and Gomo, Exnevia},
title = {Apolipoprotein B Gene Polymorphisms and Dyslipidemia in HIV Infected Adult Zimbabweans},
journal = {The Open AIDS Journal},
year = {2016},
volume = {10},
number = {1},
pages = {190--198},
doi = {10.2174/1874613601610010190}
}
EUVIMED